QDEL - Quidel Corp Stock Price, Fair Value and News

$40.08+2.19 (+5.78%)

Market Closed

Max Portfolio Pct.

Check

Valuation

Check

Stock Quality:

Max Portfolio Pct.

Check

Valuation

Check

QDEL Price Action

Last 7 days

10.8%

Last 30 days

3.1%

Last 90 days

-10.9%

Trailing 12 Months

-41.9%

QDEL RSI Chart

QDEL Valuation

Market Cap

2.7B

Price/Earnings (Trailing)

-1.44

Price/Sales (Trailing)

0.96

EV/EBITDA

-2.78

Price/Free Cashflow

-27.85

QDEL Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

QDEL Fundamentals

QDEL Revenue

Revenue (TTM)

2.8B

Rev. Growth (Yr)

-2.27%

Rev. Growth (Qtr)

14.14%

QDEL Earnings

Earnings (TTM)

-1.9B

Earnings Growth (Yr)

-56.69%

Earnings Growth (Qtr)

86.53%

QDEL Profitability

Operating Margin

97.84%

EBT Margin

-70.97%

Return on Equity

-58.57%

Return on Assets

-27.45%

Free Cashflow Yield

-3.59%

QDEL Investor Care

Shares Dilution (1Y)

0.66%

Diluted EPS (TTM)

-27.89

Revenue & Growth

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	2.9B	2.8B	2.8B	0
2023	3.1B	3.2B	3.1B	3.0B
2022	2.3B	2.8B	3.0B	3.3B
2021	0	1.7B	1.7B	1.7B
2020	0	0	0	1.7B

Get all data in R, Python etc through our Historical Stock Data APIs

About Quidel Corp

QuidelOrtho Corporation focuses on the development and manufacture of diagnostic testing technologies and solutions. The company operates through Labs, Transfusion Medicine, Point-of-Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tests that measure target chemicals in bodily fluids for the evaluation of health and the clinical management of patients; immunoassay laboratory instruments and tests, which measure proteins as they act as antigens in the spread of disease, antibodies in the immune response spurred by disease, or markers of proper organ function and health; testing products to detect and monitor disease progression across a spectrum of therapeutic areas; and specialized diagnostic solutions. The Transfusion Medicine business unit offers immunohematology instruments and tests used for blood typing to ensure patient-donor compatibility in blood transfusions; and donor screening instruments and tests used for blood and plasma screening for infectious diseases. The Point-of-Care business unit provides instruments and tests to provide rapid results across a continuum of point-of-care settings. The Molecular Diagnostics business unit offers polymerase chain reaction thermocyclers; amplification systems; and sample-to-result molecular instruments and tests for syndromic infectious disease diagnostics. The company sells its products directly to end users through a direct sales force; and through a network of distributors for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies, wellness screening centers, blood banks, and donor centers, as well as for individual, non-professional, and over-the-counter use. It operates in North America, Europe, the Middle East, Africa, China, and internationally. The company was founded in 1979 and is headquartered in San Diego, California.

CEO	Mr. Douglas C. Bryant
WEBSITE	quidelortho.com
SECTOR	Healthcare
INDUSTRY	Medical Devices
EMPLOYEES	7000

Quidel Corp Frequently Asked Questions

What is the ticker symbol for Quidel Corp? What does QDEL stand for in stocks?

QDEL is the stock ticker symbol of Quidel Corp. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Quidel Corp (QDEL)?

As of Fri Nov 22 2024, market cap of Quidel Corp is 2.7 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of QDEL stock?

You can check QDEL's fair value in chart for subscribers.

Is Quidel Corp a good stock to buy?

The fair value guage provides a quick view whether QDEL is over valued or under valued. Whether Quidel Corp is cheap or expensive depends on the assumptions which impact Quidel Corp's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for QDEL.

What is Quidel Corp's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri Nov 22 2024, QDEL's PE ratio (Price to Earnings) is -1.44 and Price to Sales (PS) ratio is 0.96. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. QDEL PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Quidel Corp's stock?

In the past 10 years, Quidel Corp has provided 0.037 (multiply by 100 for percentage) rate of return.